sci-pubs-1

Weltman AC, Rose DN. Tuberculosis susceptibility patterns, predictors of multidrug resistance, and im plications for initial therapeutic regimens at a New York City hospital. Arch Internal Med 1994; 154(19):2161—7.

Wodak A. Harm Reduction: Australia as a case study. Bull NY Acad Med 1995; 72(2):39—46.

World Health Organization. Prison reform to help control the spread of HIV. Soz Praventivmed 1993; 38(6):403.

World Health Organization, International Union Against Tuberculosis and Lung Disease. Anti tubercu losis drug resistance in the world: the WHO/IUATLD Global Project on Anti tuberculosis Drug Resistance Surveillance 1994—1997. Geneva: World Health Orga nization, 1997. WHO/TB/97.229.

World Health Organization. Global Tuberculosis Con trol: WHO Report 1999. Geneva: World Health Organi zation, 1999b. WHO/CDS/CPC/TB/99.259.

World Health Organization. Report: Basis for the development of an evidence based case manage ment strategy for MDR TB within the WHO’s DOTS strategy. Geneva: World Health Organiza tion, 1999c. WHO/TB/99.260.

World Health Organization, Regional Office for Europe. A TB epidemic in Europe. Geneva: World Health Organization, 1999.

Zhukova MP. [Main sources of the formation of contingents of tuberculosis patients with drug resistant or sensitive Mycobacterium tu berculosis isolates]. [Russian]. Probl Tuberk 1998; (4):4—5.

Zhukova MP. [Results of 30 year follow ups of pulmonary tuberculosis patients contingent with isolated drug resistant or sensitive strains]. [Rus sian]. Probl Tuberk 1997; (5):12—5.